A Pilot Study of the Combination of Retinoic Acid and Interferon-Alpha2a for the Treatment of Lymphoproliferative Disorders in Children With Immunodeficiency Syndromes
PHASE2CompletedINTERVENTIONAL
Enrollment
30
Participants
Timeline
Start Date
June 30, 1995
Study Completion Date
December 31, 2000
Conditions
HIV InfectionsImmunologic Deficiency SyndromesLymphoproliferative Disorders